A blacklegged tick, also known as a deer tick, a carrier of Lyme disease. CDC via AP
Pfizer and its partner Valneva said on March 23 that their experimental Lyme disease vaccine did not meet the target in a clinical trial, but the results were strong enough that the firms will seek regulatory approval for the shot.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/pfizer-says-lyme-vaccine-missed-trial-target-will-still-seek-approval-6002535/?utm_source=partner&utm_campaign=whatfinger
